http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005089514-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2e4a4ba842344815faabe370e037465
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2242
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L3-34635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23C9-1322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12C11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12C5-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12C11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12H1-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23C9-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L3-3463
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23B7-10
filingDate 2004-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aad9deff409ff112b2a48d8ca695ab01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9808279f7ed4c7b32ccf3a169b75839e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25850f5b793bc37833713b8536abae48
publicationDate 2005-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2005089514-A1
titleOfInvention Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections
abstract The present invention relates to antibiotically active natriuretic peptides for use as antibiotically active preparations prepared using biotechnological and recombinant methods and chemical synthesis. The antibiotically active peptides are referred to as natriubiotics. After chemical peptide synthesis, these natriubiotics can be used as human or veterinary medicaments in a suitable galenic formulation or as food additives.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008181903-A1
priorityDate 1999-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17986852
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15459053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127644607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136319641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127387780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID736301
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57320831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394565

Total number of triples: 43.